SCHEMBL29612534

SCHEMBL29612534

Nc1ccccc1-c1ccccc1-c1ccc2ccccc2n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 12/20 0.53
RAB9A P51151 12/20 0.53
KMT2A Q03164 8/20 0.53
MEN1 O00255 7/20 0.53
ALDH1A1 P00352 10/20 0.51
SMN1; SMN2 Q16637 8/20 0.51
KDM4E B2RXH2 7/20 0.51
MAPT P10636 6/20 0.51
HSD17B10 Q99714 5/20 0.51
HPGD P15428 5/20 0.51
TP53 P04637 4/20 0.51
CYP3A4 P08684 3/20 0.51
PKM P14618 3/20 0.51
GMNN O75496 1/20 0.51
THPO P40225 1/20 0.51
BLM P54132 1/20 0.51
PMP22 Q01453 1/20 0.51
PTGS2 P35354 1/20 0.49
NCF1 P14598 1/20 0.48
NOS2 P35228 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28730681 1.00 NPC1 (0.53) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL6483611 0.92 NPC1 (0.56) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL12853993 0.88 PTGS2 (0.57) NPC1RAB9AKMT2AMEN1ALDH1A1
Bromide SCHEMBL20502170 0.86 PTGS2 (0.56) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL8746410 0.78 RAB9A (0.46) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL18321130 0.77 PTGS2 (0.64) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL29986307 0.77 PTGS2 (0.64) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL24621702 0.76 RAB9A (0.50) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL30103630 0.76 PTGS2 (0.62) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL24621440 0.75 RAB9A (0.48) NPC1RAB9AKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114430743-A Thyroid hormone receptor beta agonist compounds 拓臻制药公司 2022-05-03 CN disclosed